As new laws and innovative technologies emerge, regulatory pathways in global markets are becoming increasingly more difficult to navigate. Aman Khera, Head of Global Regulatory Strategy at Worldwide Clinical Trials, discusses some trends she anticipates might impact the regulatory landscape in 2020.
Authors:
Aman Khera, MBA, FTOPRA, FRAPS
VP, Regulatory Science, Strategy and Innovation
